Multiplex-PCR assay for the deletions causing hereditary persistence of fetal hemoglobin

Molecular Diagnosis

Volumn 9, Issue 3, 2005, Pages 151-156

  Bhardwaj, Urvashi ^a   McCabe, Edward R B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; HEMOGLOBIN F;

ARTICLE; GENE AMPLIFICATION; GENE CLUSTER; GENE DELETION; GENETIC DISORDER; HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN; HEREDITY; HUMAN; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STANDARDIZATION;

FETAL HEMOGLOBIN; GENOME, HUMAN; HEMOGLOBINOPATHIES; HUMANS; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; SEQUENCE DELETION;

EID: 27744547581     PISSN: 10848592     EISSN: 10848592     Source Type: Journal    
DOI: 10.2165/00066982-200509030-00005     Document Type: Article

References (26)

1. Stamatoyannopoulous G, Grosveld F. Hemoglobin switching. In: Stamatoyannopoulous G, Majerus P, Perlmutter R, et al., editors. The molecular basis of blood diseases. Philadelphia (PA): WB Saunders, 2001: 135-82
2. Forget BG. Molecular basis of hereditary persistence of fetal hemoglobin. Ann N Y Acad Sci 1998; 850: 38-44
3. Anagnou NP, Perez-Stable C, Gelinas R, et al. Sequences located 3′ to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice. J Biol Chem 1995; 270: 10256-63
4. Calzolari R, McMorrow T, Yannoutsos N, et al. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and delta-beta thalassemia affects beta-but not gamma-globin gene expression. EMBO J 1999; 18: 949-58
5. Feingold EA, Forget BG. The breakpoint of large deletion causing hereditary persistence of fetal hemoglobin occurs within a erythroid DNA domain remote from the β-globin gene cluster. Blood 1989; 74: 2178-86
6. Bernards R, Flavell RA. Physical mapping of the globin gene deletion in hereditary persistence of foetal hemoglobin (HPFH). Nucleic Acids Res 1980; 8: 1521-34
7. Gribnau J, Diderich K, Pruzina S, et al. Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol Cell 2005; 5: 377-86
8. Henthron PS, Smithies O, Mager DL. Molecular analysis of deletions in the human β-globin gene cluster: deletion junction and location of breakpoints. Genomics 1990; 6: 226-37
9. Kutlar A, Gardiner MB, Headlee MG, et al. Heterogeneity in the molecular basis of three types of hereditary persistence of fetal hemoglobin and the relative synthesis of the Gγ and Aγ types of γ- chains. Biochem Genet 1984; 22: 21-35
10. Henthron PS, Mager DL, Smithies O, et al. A gene deletion ending within a complex array of repeated sequences 3′ to the human β-gene cluster. Proc Natl Acad Sci U S A 1986; 83: 5194-8
11. Saglio G, Camaschella C, Serra A, et al. Italian type of deletional hereditary persistence of fetal hemoglobin. Blood 1986; 68: 646-51
12. Camaschella C, Serra A, Gottardi E, et al. A new hereditary persistence of fetal hemoglobin deletion has the breakpoint with in the 3′β- globin gene enhancer. Blood 1990; 75: 1000-5
13. Kosteas T, Palena A, Anagnou NP. Molecular cloning of breakpoints of hereditary persistence of fetal hemoglobin type-6 (HPFH-6) deletion and sequence analysis of the novel juxtaposed region from the 3′ end of the β-globin gene cluster. Hum Genet 1997; 100: 441-5
14. Xu X-M, Li Z-Q, Liu Z-Y, et al. Molecular characterization and PCR detection of a deletional HPFH: application to rapid prenatal diagnosis for compound heterozygotes of this effect with β-thalassemia in a Chinese family. Am J Hematol 2000; 65: 183-8
15. Waye JS, Cai S-P, Eng B, et al. Clinical course and molecular characterization of a compound heterozygote for sickle cell hemoglobin and hemoglobin Kenya. Am J Hematol 1992; 41: 289-91
16. Huisman THJ, Carver MFH, Baysal E. A syllabus of thalassemia mutations 1-309. Augusta (GA): The Sickle Cell Anemia Foundation, 1997
17. Craig JE, Barnetson RA, Prior J, et al. Rapid detection of deletions causing δβ thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood 1994; 83: 1673-82
18. Collins FS, Cole JL, Lockwood WK, et al. The deletion in both common types of hereditary persistence of fetal hemoglobin is approximately 105 kilobases. Blood 1987; 70: 1797-03
19. Cunningham JM, Jane SM. Hemoglobin switching and fetal hemoglobin reactivation. Semin Hematol 1996; 33: 9-23
20. Bollenkens JA, Forget BG. δβ-Thalassemia and hereditary persistence of fetal hemoglobin. Hematol Oncol Clin North Am 1991; 5: 399-22
21. Katsantoni EZ, Langeveld A, Wai AWK, et al. Persistent γ-globin expression in adult transgenic mice is mediated by HPFH-2, HPFH-3, and HPFH-6 breakpoint sequences. Blood 2003; 102: 3412-9
22. Heeney MW, Delgrosso K, Robinson R, et al. Interpretation of fetal hemoglobin only on newborn screening for hemoglobinopathy. J Pediatr Hematol Oncol 2002; 24: 499-502
23. Weatherall DJ, Clegg JB. The thalassemia syndrome. 4th ed. Oxford: Blackwell Science, 2001
24. Garner C, Dew TK, Sherwood R, et al. Heterocellular hereditary persistence of fetal hemoglobin affects the haematological parameters of β-thalassemia trait. Br J Haematol 2003; 123: 353-8
25. Ghani R, Manji MA, Ahmed N. Hemoglobinopathies among five major ethnic groups in Karachi, Pakistan. Southeast Asian J Trop Med Public Health 2002; 33: 855-61
26. Costa VA, Acedo MJ, Polimeno NC, et al. Estimation of the frequency of hereditary persistence of fetal hemoglobin in brazil. Cad Saude Publica 2002; 18: 1469-71